This inventor holds 1 USPTO granted patent. Top assignees: National Institute of Health and Medical Research, The University of Nantes. Active years: 2009.
Company Filing History:
1 out of 1,853 
1 out of 156 
Years Active: 2009
Title: Elisabeth Diez: Innovator in Antitumoral Immunotherapy
Introduction
Elisabeth Diez is a prominent inventor based in Saint Fiacre sur Maine, France. She has made significant contributions to the field of immunotherapy, particularly in the development of peptides derived from the protein MMP-2. Her work focuses on innovative approaches to combat tumors through targeted therapies.
Latest Patents
Elisabeth Diez holds a patent for "Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy." This patent details the use of peptides derived from MMP-2 metalloproteinase that form T cell epitopes when presented by MHC Class I molecules. The anti-tumor therapy utilizing these peptides represents a significant advancement in cancer treatment.
Career Highlights
Throughout her career, Elisabeth has worked with esteemed institutions such as the National Institute of Health and Medical Research and the University of Nantes. Her research has been pivotal in advancing the understanding of immunotherapy and its applications in treating cancer.
Collaborations
Elisabeth has collaborated with notable colleagues, including Agnès Aubry and Yannick Guilloux. These partnerships have enriched her research and contributed to the development of innovative therapeutic strategies.
Conclusion
Elisabeth Diez is a trailblazer in the field of antitumoral immunotherapy, with her patented innovations paving the way for new cancer treatments. Her dedication to research and collaboration continues to inspire advancements in medical science.